Cargando…
Severe Rhabdomyolysis due to Presumed Drug Interactions between Atorvastatin with Amlodipine and Ticagrelor
Atorvastatin and ticagrelor combination is a widely accepted therapy for secondary prevention of ischaemic heart disease. However, rhabdomyolysis is a well-known rare side effect of statins which should be considered when treatments are combined with cytochrome P450 3A4 enzyme inhibitors. We report...
Autores principales: | Banakh, Iouri, Haji, Kavi, Kung, Ross, Gupta, Sachin, Tiruvoipati, Ravindranath |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463112/ https://www.ncbi.nlm.nih.gov/pubmed/28630772 http://dx.doi.org/10.1155/2017/3801819 |
Ejemplares similares
-
Prolonged encephalopathy and associated nonconvulsive seizures from suspected pregabalin and tapentadol: Two case reports and review of literature
por: Haji, Kavi, et al.
Publicado: (2021) -
Bleomycin‐induced pulmonary toxicity and treatment with infliximab: A case report
por: Ge, Victor, et al.
Publicado: (2018) -
Euglycemic diabetic ketoacidosis in association with dapagliflozin use after gastric sleeve surgery in a patient with type II diabetes mellitus
por: Banakh, Iouri, et al.
Publicado: (2019) -
The Concomitant Use of Atorvastatin and Amlodipine Leading to Rhabdomyolysis
por: Khan, Salman, et al.
Publicado: (2018) -
COVID-19 Is Not Comparable to H1N1 Influenza
por: Tiruvoipati, Ravindranath, et al.
Publicado: (2022)